UAB "Nobel Biocare" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,918,756 |
181,873 |
16,702 |
16,001 |
1,517 |
37.28 |
0.83 |
739,183 |
730,130 |
29,268 |
1,486,100 |
2023 |
---|
2,446,261 |
212,718 |
70,637 |
62,993 |
5,478 |
43.64 |
2.58 |
796,563 |
1,092,963 |
38,634 |
1,935,078 |
2024 |
---|
2,098,995 |
185,588 |
-46,139 |
-42,779 |
-3,782 |
42.68 |
-2.04 |
795,868 |
724,687 |
38,251 |
1,559,790 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
2,098,995 €-14 % *
Sales per employee (€)
185,588 €-13 % *
Profit before tax (€)
-46,139 €-165 % *
Net Profit (€)
-42,779 €-168 % *
Profit per employee (€)
-3,782 €-169 % *
Total profitability (%)
42.68 %-2.20 % *
Net profitability (%)
-2.04 %-179.07 % *
Equity (€)
795,868 €0 % *
Amounts Payable And Liabilities (€)
724,687 €-34 % *
Non-current Assets (€)
38,251 €-1 % *
CurrentAssets (€)
1,559,790 €-19 % *